Login
From:
Cassava Sciences, Inc.
(Uncensored)
subscribe
Oral Simufilam Slowed Cognitive Decline in a Randomized Withdrawal Trial of Mild-to-Moderate Alzheimer’s Disease | Cassava Sciences, Inc.
https://www.cassavasciences.com/news-releases/news-release-details/oral-simufilam-slowed-cognitive-decline-randomized-withdrawal
links
backlinks
Roast topics
Find topics
Find it!
The Investor Relations website contains information about Cassava Sciences, Inc.'s business for stockholders, potential investors, and financial analysts.
